about
Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteinsInhibitors of apoptosis proteins in human cervical cancer.XIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 DimerizationInteraction of a Cyclic, Bivalent Smac Mimetic with the X-Linked Inhibitor of Apoptosis Protein † ‡Structure-Based Design, Synthesis, Evaluation, and Crystallographic Studies of Conformationally Constrained Smac Mimetics as Inhibitors of the X-linked Inhibitor of Apoptosis Protein (XIAP) †A novel compound NSC745885 exerts an anti-tumor effect on tongue cancer SAS cells in vitro and in vivoVariations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injuryCaspase inhibition with XIAP as an adjunct to AAV vector gene-replacement therapy: improving efficacy and prolonging the treatment windowXIAP protection of photoreceptors in animal models of retinitis pigmentosa.MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein.High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems.Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53.Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins.Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancerActivation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses.SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent mannerFascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathwayCyclopeptide Smac mimetics as antagonists of IAP proteins.Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells.The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2.Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.Markers of apoptosis induction and proliferation in the orbitofrontal cortex in alcohol dependence.A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus.Increase in retinal ganglion cells' susceptibility to elevated intraocular pressure and impairment of their endogenous neuroprotective mechanism by age.Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity.Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells.X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma.E3 ubiquitin ligases as cancer targets and biomarkers.Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra.Tumor-specific gene expression using the survivin promoter is further increased by hypoxiaExpression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorderProtease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein.Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.Lipid-conjugated Smac analogues.
P2860
Q24300020-94605EE5-684C-4C80-BA55-4193AC5CEE7BQ25255294-AFDA3ABC-D26D-4241-BD3E-2CAA2EAFE810Q27645534-5B9E0A2D-2C7E-49FE-8A2B-648110592AB0Q27651733-40EABED1-C260-4F2E-97BC-DA4941737C6AQ27652682-8F65CCCD-D238-4BC5-86A6-F8A4FB7333DFQ28541985-97882A1E-254D-425B-81C6-C456E36BBE8BQ28583230-60C0C525-38A7-479B-A80D-74D3976BCA79Q28729935-916008CA-AB88-4F8A-8B66-B9955D520FE9Q33279531-642976CB-7BE8-4ED0-A940-8345953AD2BCQ33302912-9026A514-4BD7-461C-9CE8-661CEF97A200Q33515420-574D0C27-F14F-4C32-8E36-32D0639BAAE2Q33703976-12CCC218-A2EA-4F5D-8E81-A179A7D458D9Q33765623-E131CC77-6FAD-49FA-8B99-BB048C52CF55Q34012236-1F9610D8-FE71-4BBC-A632-E83AAF0E1608Q34019667-647337FD-5724-45BA-9A97-51AC6542C74FQ34072291-B7586955-D6D5-46D6-A552-F1AAF3E4A3FCQ34074412-DBD41143-8BB7-4323-94DE-5232E7288F7FQ34116053-8BD4DA5F-9DA5-454E-B1F3-DBC6EE982DB1Q34130066-0A004281-1A42-4940-A6A6-D54D7236668DQ34189300-7B4C6D8C-CFD6-4E7D-A050-F6D24E1CE9CBQ34217456-C2B0D867-103C-44F7-BC22-51FF86F388B0Q34229779-E228B6F7-1CFC-4703-999C-7D86C6C72884Q34354577-565DCF5C-0E3C-4171-A2FA-77A821811240Q34382271-FDCD1108-1DDA-427A-B6FC-CBBAE322810CQ34424820-79712B22-B06A-4602-B743-F63FEAD3F2E5Q34462937-2E37C698-E195-4EDB-956A-2ADBECD9C192Q34557323-75FAED84-6DB7-4334-978F-B693E79FBD19Q34573986-32185253-C378-457F-B4B5-B4C32E54282FQ34626385-2A4BFA42-6CB6-4609-8292-82C00A888D1FQ35022255-84EA9A7F-DB59-4134-9418-9F6696EAF6FBQ35024837-5D2AD8DC-E27E-4993-85E8-3D7C9DC461D1Q35072876-F41C0744-A6B9-49E1-92C3-C3A460092CEAQ35078238-88E78CE0-A522-4D41-A395-9835F4522411Q35082710-66C48C06-A5D2-43F7-8BC8-3FA67CF752AAQ35117678-B473D807-4E34-4716-9C09-5C798FA519C1Q35184871-18F1F47F-B459-4FA8-82AC-66C28BEB92A2Q35211953-FAD77454-8C69-469C-965B-CD528763D1E7Q35551870-9F8C1AAB-308F-41AB-B921-687C9BDE6C57Q35558056-3653BE74-3963-4264-8530-B118E175C253Q35780628-210668D2-7F60-433D-ACE7-C4EB2632DAE7
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
XIAP: apoptotic brake and promising therapeutic target.
@ast
XIAP: apoptotic brake and promising therapeutic target.
@en
XIAP: apoptotic brake and promising therapeutic target.
@nl
type
label
XIAP: apoptotic brake and promising therapeutic target.
@ast
XIAP: apoptotic brake and promising therapeutic target.
@en
XIAP: apoptotic brake and promising therapeutic target.
@nl
prefLabel
XIAP: apoptotic brake and promising therapeutic target.
@ast
XIAP: apoptotic brake and promising therapeutic target.
@en
XIAP: apoptotic brake and promising therapeutic target.
@nl
P356
P1433
P1476
XIAP: apoptotic brake and promising therapeutic target
@en
P2093
R G Korneluk
P2888
P304
P356
10.1023/A:1011379307472
P577
2001-08-01T00:00:00Z
P6179
1007962126